Related Experiment Video
Updated: May 23, 2026
09:43
Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
[Secondary gliosarcoma: case report].
Rajae Tahri1, Omar Boulahroud, Khadija Setti
1Service d'anatomie pathologique, hôpital militaire d'instruction Mohammed V de Rabat, Rabat, Maroc. rajae.tahri@gmail.com
Annales De Pathologie
|April 24, 2012
Summary
Gliosarcoma, a rare central nervous system tumor, can arise from glioblastoma, particularly after radiotherapy. This case highlights diagnostic specificities of secondary gliosarcoma, distinguishing it from glioblastoma.
Area of Science:
- Neuro-oncology
- Pathology
- Central Nervous System Tumors
Background:
- Gliosarcoma is a rare central nervous system tumor comprising both gliomatous and sarcomatous components.
- It can develop from glioblastoma, especially following radiotherapy treatment, indicating a phenotypic transformation.
- Understanding these rare tumors is crucial for accurate diagnosis and treatment.
Observation:
- This case report focuses on secondary gliosarcoma, emphasizing its unique diagnostic features.
- Gliosarcomas may present macroscopically similar to meningiomas.
- Metastases are reported more frequently in gliosarcoma than glioblastoma.
Findings:
- EGFR mutations are infrequently observed in gliosarcoma compared to glioblastoma.
- The phenotypic change from glioblastoma to gliosarcoma is a key characteristic.
- Diagnostic challenges arise from the mixed cellular components and potential mimicry of other tumors.
Implications:
- Accurate diagnosis of gliosarcoma is essential due to its distinct biological behavior and metastatic potential.
- Recognizing the specificities of gliosarcoma aids in differentiating it from primary glioblastoma.
- Further research into the pathogenesis and treatment of gliosarcoma is warranted.
